R-IT should be run to full completion - what we want at interim is approval for ANCHOR and expanded indication, plus wide spread publicity about how great V + statin is at reducing the rates of FIRST CVE.
Kiwi, you are not, not unaware (triple negative?) of my true R-IT stop date! You "assigned" Nov 15 to me but I am more optimistic, and will go for 4th of July. Now that you are "not unaware" of the actual date we can move on. JL and I both think July, LOL!!! The early and wide divergent graph of JELIS subgroup was the first thing that caught my eye about AMRN and Vascepa years ago and I still believe it!